Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Wolfspeed (WOLF) - free report >>
Arcadia Biosciences, Inc. (RKDA) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Wolfspeed (WOLF) - free report >>
Arcadia Biosciences, Inc. (RKDA) - free report >>
Image: Bigstock
New Strong Buy Stocks for October 24th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Baudax Bio, Inc. : This pharmaceutical company that develops and commercializes products for hospitals has seen the Zacks Consensus Estimate for its current year earnings increasing 37% over the last 60 days.
Baudax Bio, Inc. Price and Consensus
Baudax Bio, Inc. price-consensus-chart | Baudax Bio, Inc. Quote
Wolfspeed, Inc. (WOLF - Free Report) : This powerhouse semiconductor company has seen the Zacks Consensus Estimate for its current year earnings increasing 33.3% over the last 60 days.
Wolfspeed Price and Consensus
Wolfspeed price-consensus-chart | Wolfspeed Quote
GH Research PLC (GHRS - Free Report) : This clinical-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 18.8% over the last 60 days.
GH Research PLC Price and Consensus
GH Research PLC price-consensus-chart | GH Research PLC Quote
Arcadia Biosciences, Inc. (RKDA - Free Report) : This manufacturer of plant-based health and wellness products has seen the Zacks Consensus Estimate for its current year earnings 30.8% over the last 60 days.
Arcadia Biosciences, Inc. Price and Consensus
Arcadia Biosciences, Inc. price-consensus-chart | Arcadia Biosciences, Inc. Quote
Braemar Hotels & Resorts Inc. (BHR - Free Report) : This real estate investment trust which is focused on investing in luxury hotels and resorts has seen the Zacks Consensus Estimate for its current year earnings increasing 5.3% over the last 60 days.
BRAEMAR HOTELS & RESORTS INC. Price and Consensus
BRAEMAR HOTELS & RESORTS INC. price-consensus-chart | BRAEMAR HOTELS & RESORTS INC. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.